JHDAAI Research Projects
JHDAAI researchers generate analysis and insights to support improved pharmaceutical access and equity in the US. Learn more about our current research topics here, and explore additional policy briefs and information in our resource library.
Medicare Drug Price Negotiation
Our researchers are looking at how Medicare’s ability to negotiate drug prices impacts out-of-pocket costs for beneficiaries as well as premiums for Medicare’s prescription drug benefit.
Drug Supply Chain
The U.S. pharmaceutical market relies heavily on production facilities around the globe, often with little redundancy or competition. Many active pharmaceutical ingredients are produced at a single global facility. JHDAAI researchers are examining this system and the significant vulnerabilities it creates in the U.S. drug supply chain.
Drug Affordability
JHDAAI researchers are looking at ways to make the U.S. pharmaceutical market more competitive, delivering drugs of greater value at lower cost.
Drug Regulation and Legislation
JHDAAI research provides evidence for policy recommendations that balance the need for innovation, patient access to medications, and control of overall medical costs to payers in our health care system.